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ess: antoine.magnan@aSummary Immunological studies claimed that atopic and non-atopic asthma share
more similarities than differences. However, these two phenotypes of asthma are
considered to be distinguishable upon distinct clinical patterns, which were not
systematically assessed before in a large population. We studied characteristics
discriminating atopic from non-atopic asthma among 751 asthmatic patients and 80
factors were analysed in univariate and multivariate analysis.
Age, age of onset of asthma, female/male ratio were higher in non-atopic
(n ¼ 200) than in atopic (n ¼ 551) asthmatics. Familial asthma, seasonal symptoms,
rhinitis, conjunctivitis, allergen-triggered symptoms, improvement in altitude,
exercise-induced asthma were associated with atopy. Non-atopic asthmatics
displayed lower FEV1 and FVC. Smoking was more frequent and asthma was more
severe in these patients. Younger age, early onset, male sex, rhinitis and smoking
were independent factors discriminating atopic from non-atopic asthma.
This study establishes in a large population of asthmatics that although
similarities exist between atopic and non-atopic asthma, two clinical phenotypes
can still distinguish both kinds of asthma.
& 2004 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserv
-91-74-46-30; fax: +33-4-
p.hm.fr (A. Magnan).Introduction
Rackeman first reported the distinction of two
clinical patterns of asthma.1 This author opposed
in a study of a limited number of patients a form
of the disease in which extrinsic factors wereed.
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peculiar triggering factor could be found. He
therefore called the first ‘‘extrinsic asthma’’ and
the second ‘‘intrinsic asthma’’. For Rackeman, the
first type is easy to diagnose, begins before the age
of 30, is associated to ‘‘vasomotor rhinitis’’ and to
allergy. The second type is more difficult to
diagnose and is associated to ‘‘polypoid sinusitis’’.
More recently, atopic vs. non-atopic asthma were
opposed upon the presence of personal or familial
history of allergies and the result of skin prick tests
to common aeroallergens irrespectively to the
triggering of symptoms by allergens.2,3 This classi-
fication was used in the recent years in the so-
called ‘‘intrinsic asthma study’’, built to analyse
immunological differences between atopic and
non-atopic asthma.4 Most results obtained in this
study led to the conclusion that both kinds of
asthma share more similarities than differences.5
This prompted us to reassess in a large population
of asthmatics whether the distinction of atopic and
non-atopic asthma allows really the distinction of
the clinical patterns suggested by Rackeman, and in
what extent other characteristics can be attribu-
table to one type or to the other.
Herein, we compared upon the presence of atopy
in a large population of asthmatic subjects, a series
of clinical and functional parameters collected
prospectively.Methods
The database, ‘‘Asthmaexpert’’
Patients included are those included in a database
designed by the Association pour la recherche en
intelligence artificielle (ARIA) in order to build
the validated expert system for the diagnosis and
management of asthma, ‘‘Asthmaexpert’’.6,7
As previously described,6,7 eight senior clinical
experts in asthma collected data over a 3-year
period. All asthmatic patients were enrolled pro-
spectively. In all patients, asthma had been
diagnosed for more than 1 year and the diagnosis
was confirmed using the American Thoracic Society
criteria.8 For each patient, all the experts agreed
the diagnosis of asthma. For entry into the study,
documentation of a minimum of 15% reversibility of
airways obstruction during the previous year, or a
bronchial hyperactivity for patients without airway
obstruction, was required. Smoking was not an
exclusion criterion. Asthmatic patients were trea-
ted according to international recommendations. A
total of 888 asthmatics patients were prospectivelyincluded in the database (400 males and 488
females aged 11 to 88 years old) during their first
visit to a chest physician. For each patient, data
obtained from a systematic questionnaire, physical
examination, lung function tests and skin prick
tests (SPT) were collected as previously pub-
lished.9,10 Briefly, SPT were performed with com-
mon aero-allergen extracts (house dust mites,
moulds, cat and dog dander, tree and grass pollen
according to regional exposures). Codeine phos-
phate (9%) was used as positive control and a
negative control test was performed with buffer to
discard false positive results. SPT were considered
positive if the wheal diameter was larger than this
induced by the positive control.8 When positive or
negative controls were unreliable or when the
wheal diameter was smaller than this induced by
the positive control, patients were excluded from
the analysis. SPTwere performed by trained nurses
but SPT results were assessed by the clinical
experts.
After compiling the patient’s data, the expert
system proposes five different conclusions:6 sever-
ity and control of asthma, precipitating factors,
advice such as environmental control measures,
further investigations which might be required and
a therapeutic plan. Asthmaexpert scores from 1 to
5 severity and control according to clinical fea-
tures, instability of the disease, pulmonary func-
tion testing and current treatment in the past
month (control) or in the past year (severity).6,7
Study design
Definition of the patient groups
Patients were first classified into two groups for
analysis according to the atopic status. Patients
with at least one positive SPT to a common
aeroallergen (house dust mite (HDM), moulds, cat
and dog dander and pollens) were considered as
atopic asthmatics. Patients with negative SPTwere
considered as non-atopic.
Variables analysed
The following variables were considered for
analysis:
Questionnaire Characteristics of patients: Age, sex, body/mass
index. Symptoms during the last week: Cough, dyspnea,
wheezing. History of asthma: Age at onset of asthma,
family history of asthma, periodicity of asthma
(perennial or seasonal and distribution among
the seasons).
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Rhinitis with their characteristics (periodicity,
anosmia, rhinorrhea, sneeze, nasal pruritus),
nasosinusal polyposis, eczema, conjunctivitis,
urticaria, anaphylactic shock, angiooedema. Triggering or protecting factors reported as
history: Allergens, altitude, dampness, dryness,
wind, cold, exercise, laugh, aspirin, menstrua-
tion, pyrosis. Environmental exposure: Occupation, pollution,
dampness, dusty house, smoking (current, past
and passive, mean of pack-years). Number of mild or severe exacerbations in the
last month and in the last year, defined according
to the FACET study.11
Respiratory function tests Basal FEV1, FVC. Reversibility upon bronchodilation: FEV1 was
measured 15min after inhalation of 200 mg of
albuterol. The difference between the FEV1
obtained was divided by the basal FEV1 to obtain
a percentage of reversibility.
‘‘Asthmaexpert’’ conclusions Severity score.
 Control score.Statistical analysis
The database was analysed by two chest physicians
(AN and AM) helped by a statistician (AL). Catego-
rical variables were analysed with the Chi-square
test. When variables were in class, we used anTable 1 Comparison between atopic and non-atopic ast
asthma.
Atopics N ¼ 551
Age (years,7SEM) 35.471.1
Sex (% females) 52.3
Age at onset of asthma
(years7SEM)
17.471.4
Familial asthma (%) 43.2
Seasonal or seasonal increase
of symptoms (%)
44.5
Symptoms within the last week
Cough (%) 48.64
Dyspnea (%) 69.33
Wheezing (%) 29.6overall Chi-square test and a Chi-square test for
each class. Continued variables were analysed with
Student’s t-test or analysis of variance. Multi-
variate logistic regression analysis was used to
assess the independent factors increasing the risk
of non-atopic asthma compared to atopic asthma
compared to outdoor allergens. We performed a
backward stepwise analysis leading to an estimate
of the odds-ratio, together with its confidence
interval and degree of significance. Variables
included in the model were those for which the
P-value was lower or equal to 0.25 in the univariate
analysis. A P-value less than 0.05 was considered as
statistically significant. The SAS software package
version 6.12 (SAS Institute Inc., Cary, NC, USA) was
used for all computations.Results
Among the 888 asthmatic patients included in the
database, 137 were excluded from the analysis
because of inconclusive SPT (unreliable positive or
negative controls or weakly positive tests). Among
the 751 patients analysed (414 females, 55.12% and
337 males, 44.87%) atopy was found in 551
(73.37%), and 200 were non-atopic (26.63%).Characteristics of subjects history and
symptoms of asthma
Atopic asthmatics were younger than non-atopics
and there were more females among the latter. The
body/mass index did not differ significantly be-
tween group (Table 1).hmatic. Characteristics of the patients and history of
Non-atopics N ¼ 200 P-Value
46.171.9 o 0.0001
63 0.009
31.272.3 o 0.0001
34 0.0234
26.7 o 0.0001
59.50 0.0083
76.14 0.0005
30.95 0.81
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asthma was more frequent in atopic patients.
Seasonal asthma or seasonal increases of asthma
symptoms were more frequent in these patients. In
patients with seasonal increase of symptoms, spring
and autumn were the seasons involved in both
groups.
Cough was more frequent in atopic asthmatics
whereas the frequency of wheezing was not
different.
Dyspnea was more frequent in non-atopics.
Rhinitis and other associated diseases
Familial history of rhinitis and current rhinitis were
more frequent in atopic asthmatics. In these
patients, seasonality of rhinitis (seasonal rhinitis
or seasonal increase of rhinitic symptoms) was
more common. In patients with seasonality of
rhinitis, spring was involved in both groups. Among
patients with rhinitis, anosmia was more frequent
in non-atopic asthmatics albeit nasal pruritus
predominated in the atopic counterparts. Sneezing
and rhinorrhea tended also to more frequent in
atopic asthma but the difference was not signifi-
cant (Table 2).
Conjunctivitis and eczema were more frequent in
atopic subjects, although the difference was
significant for conjunctivitis only. Familial eczema
predominated in these patients. There was no
statistically significant difference for others asso-
ciated pathologies, notably for other allergic
diseases (history of anaphylactic shock, Quincke
oedema, and urticaria).Table 2 Comparison between atopic and non-atopic ast
Atopics N ¼ 551
Rhinitis (%) 62.6
Polyposis (%) 16.8
Familial rhinitis (%) 23.4
Seasonal or seasonal increase
of rhinitis symptoms (%)
44.3
Anosmia (% of rhinitics) 20.3
Rhinorrhea (% of rhinitics) 80
Nasal pruritus (% of rhinitics) 25.8
Sneezing (% of rhinitics) 72.7
Conjunctivitis (%) 15.6
Eczema (%) 5.3
Familial eczema (%) 11.6
Anaphylactic shock (%) 1.1
Quincke oedema (%) 5.6
Urticaria (%) 11.1Triggering factors and environmental
exposure
Allergens were triggers of asthma and rhinitis
symptoms preferentially in atopic asthmatics.
Improvement in altitude was associated with atopy,
and 83% of atopic subjects improving in altitude
displayed a positive SPT to HDM. Exercise-induced
asthma was more frequent in atopics. There was
no significant difference for other triggering fac-
tors, notably for aspirin intake, laughing or pyrosis
(Table 3).
Smoking was more important in non-atopic
asthma. This variable included current smokers,
past-smokers and passive smokers. Thus 29.39% of
atopics and 38.49% of non-atopic patients were
current or past smokers; 13.61% of atopic and
15.51% of non-atopic asthmatics were passive
smokers. Mean of pack-years was higher in non-
atopic asthmatics, but this difference was due to
the higher age of these patients, as it disappeared
after adjustment on age. There was no significant
difference for other environmental exposures.Asthma symptoms and functional data
Asthma exacerbations in the last month and in the
last year, respectively, were more frequent in non-
atopic asthmatics. FEV1 and FVC values were lower
in these patients, and both severity and control
scores given by Asthmaexpert were higher in
these patients. The reversibility of FEV1 after
bronchodilation was available in 406 atopics andhmatics. Rhinitis and other associated diseases.
Non-atopics N ¼ 200 P-value
47 o0.0001
21 0.2584
14 0.005
25.5 0.0010
31.9 0.0172
71.3 0.0697
11.7 0.0003
63.8 0.0915
8.5 0.0123
2 0.0538
6.5 0.0411
0.5 0.45
5.5 0.94
12 0.72
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Table 3 Comparison between atopic and non-atopic asthmatics. Triggering factors and environmental
exposure.
Atopics N ¼ 551 Non-atopics N ¼ 200 P-value
Exercise (%) 52.3 41 0.0063
Laugh (%) 40.8 37.5 0.4095
Allergen (%) 69.5 32.5 0.0001
Pyrosis (%) 21.4 25 0.2974
Aspirin (%) 7.5 6 0.73
Improvement in altitude (%) 31.2 15.5 o 0.0001
Dusty house (%) 5.1 0 0.0012
Smokers (%) 43 54 0.0076
Pack-year (mean7SEM) 6.670.9 13.472.5 0.0018
Table 4 Comparison between atopic and non-atopic asthmatics. Asthma symptoms and functional data.
Atopics Non-atopics P-value
Patients with more than one exacerbation in the last month (%) 69.4 79.6 0.0361
(n ¼ 551) (n ¼ 200)
Patients with more than 1 exacerbation in the last year (%) 45.7 58.9 0.0171
(n ¼ 551) (n ¼ 200)
FVC (% of predictive value7SD) 94717 91719 0.046
(n ¼ 551) (n ¼ 200)
FEV1 (% of predictive value7SD) 82722 76722 0.004
(n ¼ 551) (n ¼ 200)
FEV1 reversibility after albuterol (% of increase of FEV17SEM) 17.570.008 17.570.016 0.99
(n ¼ 406) (n ¼ 159)
Severity score 19.4 39.6 o0.0001
(n ¼ 551) (n ¼ 200)
Control score 6 12 0.0017
(n ¼ 551) (n ¼ 200)
Table 5 Multivariate analysis. Atopic asthmatics compared to non-atopic asthmatics.
Odds ratio 95% confidence interval P-value
Age 0.97 0.96–0.99 0.002
Age at onset of asthma 0.97 0.95–0.98 o0.0001
Male sex 1.59 1.09–2.32 0.0154
Rhinitis 1.47 1.02–2.12 0.0401
Smoking 0.53 0.37–0.77 0.0009
Phenotypes of asthma revisited upon the presence of atopy 351159 non-atopics. The percentage obtained was
similar (17.5%) in both groups (Table 4).Multivariate analysis
The multivariate analysis showed that age, age at
onset of asthma, sex ratio, rhinitis and smoking
were independent discriminating factors between
atopic and non-atopic asthma. Atopic subjects
were younger, started their asthma earlier, weremore frequently males, were more often rhinitic
but were less smokers than the non-atopic counter-
parts (Table 5).Discussion
This study is the first that compares atopic to
non-atopic asthma inasmuch as 751 adult asth-
matics. It demonstrates that despite immunological
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two distinct phenotypes. Some discriminating fac-
tors were previously reported in smaller surveys,
such as age of the patients, age of onset of asthma,
and gender.1,12,13 But other differences were not
clearly established before. Rhinitis, conjunctivitis
and eczema, all allergic diseases related to atopy,
were more frequent in atopic asthmatics. Similarly,
familial asthma, eczema and rhinitis were more
frequently present in these patients, reminding
that atopy and related diseases are traits inherited
together.14 In smaller studies, familial asthma was
found as frequently in both types15 of asthma. As
expected, asthma and rhinitic symptoms were
more frequently seasonal in atopics. More directly,
symptoms were triggered by allergen exposure
more than three times as frequently in atopic as
in non-atopic asthmatics. Conversely, allergies
unrelated to atopy such as urticaria, Quincke
oedema or anaphylactic shocks were as rare in
both groups.
The prevalence of rhinitis was relatively low in
both groups, as regard to the published litera-
ture.16 This is due to the fact that diagnosis was
done only on the presence or absence of symptoms
(rhinorrhea, nasal obstruction, sneezing, nasal
pruritus or anosmia), but without nasal examina-
tion, which would have probably diagnosed many
non-symptomatic rhinitis. Nevertheless, this should
not have modified the differences observed be-
tween groups given the large number of patients.
Rhinitis was more frequent in atopic asthmatics,
which is probably related to atopic rhinitis. It was
still present in half of non-atopics, probably due to
non-allergic eosinophilic rhinitis or polyposis.17,18 A
previous study concerning a smaller population did
not find any difference in the prevalence of rhinitic
symptoms.12 Nasal pruritus, rhinorrhea and sneez-
ing were more frequent in atopic asthmatics
although anosmia predominated in non-atopic
counterparts. Again this difference could be re-
lated, respectively, to atopic rhinitis in the former
and to nasal polyposis in the latter. However, nasal
polyposis was not found more frequently in non-
atopic asthmatics. This is controversial with pre-
vious studies and should be considered cautiously,
as polyposis was not confirmed by endoscopic or
radiologic investigations. Another hypothesis is that
some asthmatics bearing the ‘‘intrinsic’’ phenotype
with polyposis could display positive SPT and be
misclassified. Indeed, the prevalence of atopy in
the general population is around 30%,18 so that 30%
of patients with unrelated diseases display positive
SPT. Thirty per cent is the frequency of positive SPT
among subjects with polyposis, and could therefore
be the same among ‘‘intrinsic’’ asthmatics.19Accordingly, aspirin-induced asthma, considered
as a form of non-atopic asthma and frequently
associated to nasosinusal polyposis was not differ-
ently incriminated in each group.20
Other discriminating factors are not apparently
related to the atopic diathesis. Exercise-induced
asthma was more frequent in atopic asthmatics,
but as these patients are younger they possibly
have more exercise practice. Indeed exercise-
induced asthma was still found in 41% of non-
atopics. Accordingly, laugh-induced asthma, which
mechanisms are probably close to these of ex-
ercise-induced asthma, was as frequent in atopic as
in non-atopic asthma.21 Lastly, cough and dyspnea
was more frequently reported by non-atopics,
which can be related to asthma severity.
Indeed, asthma is more severe in non-atopics in
univariate analysis. This finding was reported
previously in some studies but not in others.22,23 A
previous work studied a sample of 471 patients of
the database of ARIA. Patients were classified as
atopic or not by ‘‘Asthmaexpert’’ upon results of
SPT and/or of Phadiatop assay and the presence of
seasonal rhinitis, conjunctivitis, and atopic ecze-
ma. Asthmaexpert concluded that atopics were
younger and displayed a milder asthma.9 Inouye et
al.24 showed that asthma severity was similar in
SPT negative vs. SPT positive patients when groups
were paired on age and duration of asthma.
Smoking could be the reason of an increased
severity of asthma in non-atopics. Indeed, smoking
was more frequent in this group, which can be
related to the late onset of asthma in these
patients. Indeed, they might have begun to smoke
before the onset of asthma whereas the atopic
counterparts did not start smoking, as they were
already asthmatics.
The atopic to non-atopic ratio, 2.76, is concor-
dant with published prevalence surveys. In the
SAPALDIA study, asthma prevalence was of 7%, one-
third being non-atopic.25 More recently, in the
epidemiological study on the genetics and environ-
ment of asthma (EGEA) we found 2 atopics for 1
non-atopic.12
The existence of two distinct phenotypes of
asthma suggest that respective genotypes could
be different. However, although several genes have
been shown to be linked to asthma, no relationship
to the atopic status of asthmatic patients was
reported. Recently, a common susceptibility locus
for asthma-related traits was characterized, which
was relevant both for asthma and high IgE levels.26
Most studies of inflammatory cells and mediators
in asthma showed similar findings between atopic
and non-atopic asthma.4,5 Indeed, IgE are elevated
in serum and an activation of Th2 cells is found in
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‘‘intrinsic asthma study’’.27–29 By contrast, other
studies have found differences between both types
of asthma. Walker et al. showed that IL-4 was
increased only in atopic asthmatics.30 Broncho-
alveolar lavage cells expressing the a subunit of the
granulocyte-macrophage colony-stimulating factor
receptor (GM-CSFr), expressed by alveolar macro-
phages, were increased in non-atopic but not in
atopic asthma.31 All of these studies, however,
because of the invasive tools necessary to approach
in situ the airways inflammation concerned a
limited number of patients, so that negative
conclusions cannot necessarily be driven from
negative results. Indeed when using induced spu-
tum, a recently proposed non-invasive tool of
investigating inflammation in asthma, Green et al.
identified a group of asthmatics with high bronchial
neutrophilia and normal eosinophilia.32 These
patients were more likely to be female and non-
atopic and shared many of the characteristics of
our non-atopic group of patients, with higher
severity, higher age, and late onset of asthma.
This suggests that differences between atopic
and non-atopic asthmatics in inflammation could
be detected in induced sputum rather than in BAL
or biopsies.References
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